Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FGF22-IN-1 is a potential CD4 N-terminal immunoglobulin variable region-like domain (CD4 D1) inhibitor.FGF22-IN-1 inhibits the interaction between CD4 and major histocompatibility complex (MHC) class II proteins and suppresses the immune response.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 45.00 | |
5 mg | In stock | $ 106.00 | |
10 mg | In stock | $ 172.00 | |
25 mg | In stock | $ 328.00 | |
50 mg | In stock | $ 538.00 | |
100 mg | In stock | $ 766.00 | |
500 mg | In stock | $ 1,550.00 |
Description | FGF22-IN-1 is a potential CD4 N-terminal immunoglobulin variable region-like domain (CD4 D1) inhibitor.FGF22-IN-1 inhibits the interaction between CD4 and major histocompatibility complex (MHC) class II proteins and suppresses the immune response. |
Molecular Weight | 269.32 |
Formula | C14H11N3OS |
CAS No. | 113143-13-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 80 mg/mL (297.04 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FGF22-IN-1 113143-13-8 Others inhibitor inhibit